News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
In 2022, Startup Genome's Global Startup Ecosystem Report ranked Philadelphia as the 27th-best startup ecosystem in the world and number eleven within the U.S.
This new form of treatment turns off a cancer-attracting function in human blood vessels, which disables the pathways through which the cancer cells travel.
The symposium featured presentations and research posters by CiPD faculty and trainees in the Center’s NIDCR T90/R90 Postdoctoral Training Program as well as invited speakers.
From June 19-20, PCI attended 2023 Tech Connect World Innovation Conference and Expo, an annual event that brings together the creators of breakthrough technologies with corporations.
Qishui (Tracy) Chen, Assistant Director of Licensing, Physical Sciences, and Engineering shared and discussed a wide range of available drug delivery technologies come out of Penn.
Engheta was granted this prestigious award, which is one of the world’s oldest science and technology awards, for his transformative innovations in engineering novel metamaterials.
The FDA first approved of chimeric antigen receptor (CAR) T cell therapy in 2017, and Penn Medicine has since been dedicated to finding further applications to the treatment.
This research team has developed a new way to accurately target and quickly destroy fungal cells in the mouth by using nanorobots guided by magnets.
Henry Daniell and his team of researchers developed a new plant-based, oral method of insulin delivery that regulates blood sugar levels similar to natural insulin.
Three staff members spoke at Track 5: “$tuff You Should Know about Starting Up and Spinning Out a Cell and Gene Biotech.”